Scientific Studies

Unlike many other food supplements, Bimuno® is underpinned by a large and growing body of published scientific evidence.


A mixture of trans-Galactooligosaccharides reduces markers of Metabolic Syndrome and modulates the fecal microbiota and immune function of overweight adults


Background: The gut microbiota is altered towards a less beneficial composition in overweight individuals which may be linked to an increased risk of metabolic syndrome, a set of disorders that increases the risk of developing cardiovascular disease, type 2 diabetes and cancer.

Aim: To investigate the efficacy of trans-galactooligosaccharide (B-GOS) in altering the colonic microflora of overweight individuals and its impact on risk factors of metabolic syndrome.

Methods: 44 overweight adults with >3 risk factors associated with metabolic syndrome completed a 12 week double blind placebo controlled clinical crossover trial. Patients were randomized to receive either 5.5g prebiotic, or 5.5g/d placebo.

Fecal samples were taken prior to, during and at the end of the trial for bacterial analysis as well as whole blood for C-reactive protein, insulin, and full blood count and immunological analysis. BP, BMI and waist circumference were also recorded.

Results: B-GOS increased the number of fecal bacteria at the expense of less desirable groups. Increases in fecal secretory IgA and decreases in fecal calprotectin, plasma C-reactive protein, insulin, total cholesterol (TC), triglycerides (TG) and the TC:HDL cholesterol ratio were also observed.

Conclusion: Administration of B-GOS to overweight adults resulted in positive effects on the composition of the gut microbiota, the immune response and insulin, TC and TG concentrations. B-GOS may be a useful candidate for the enhancement of gastrointestinal health, immune function, and the reduction of metabolic syndrome risk factors in overweight adults.


Vulevic J et al. J. Nutr.2013;143:324-331




Back to Scientific Studies


This section is an information and educational resource for healthcare professionals, scientists, researchers and journalists. It is not intended for consumers. If you wish to purchase Bimuno please click here

Back to the top